BioMaxima S.A. (WSE:BMX)
12.95
-0.10 (-0.77%)
May 13, 2025, 5:00 PM CET
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Microbiology | 24.63M |
Log In |
Log In |
Log In |
Log In |
Microbiology Growth | 0.86% |
Log In |
Log In |
Log In |
Log In |
Analytics | 20.21M |
Log In |
Log In |
Log In |
Log In |
Analytics Growth | -82.84% |
Log In |
Log In |
Log In |
Log In |
Other | 1.95M |
Log In |
Log In |
Log In |
Log In |
Other Growth | 14.45% |
Log In |
Log In |
Log In |
Log In |
Products | - |
Log In |
Log In |
Log In |
Log In |
Products Growth | - |
Log In |
Log In |
Log In |
Log In |
Goods and Materials | - |
Log In |
Log In |
Log In |
Log In |
Goods and Materials Growth | - |
Log In |
Log In |
Log In |
Log In |
Change in Products | - |
Log In |
Log In |
Log In |
Log In |
Change in Products Growth | - |
Log In |
Log In |
Log In |
Log In |
Production Costs for the Entity's Own Needs | - |
Log In |
Log In |
Log In |
Log In |
Production Costs for the Entity's Own Needs Growth | - |
Log In |
Log In |
Log In |
Log In |
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Poland | 31.03M |
Log In |
Log In |
Log In |
Log In |
Poland Growth | -76.03% |
Log In |
Log In |
Log In |
Log In |
European Union | 10.49M |
Log In |
Log In |
Log In |
Log In |
European Union Growth | 20.23% |
Log In |
Log In |
Log In |
Log In |
Other Countries | 5.27M |
Log In |
Log In |
Log In |
Log In |
Other Countries Growth | -7.14% |
Log In |
Log In |
Log In |
Log In |